{"id":987512835,"date":"2026-10-26T14:02:51","date_gmt":"2026-10-26T14:02:51","guid":{"rendered":"https:\/\/branding-science.com\/?p=987512835"},"modified":"2026-10-26T14:03:15","modified_gmt":"2026-10-26T14:03:15","slug":"de-la-perte-dexclusivite-a-la-preparation-du-lancement-grace-a-la-demarche-patiente-pour-orienter-le-portefeuille","status":"publish","type":"post","link":"https:\/\/branding-science.com\/fr\/de-la-perte-dexclusivite-a-la-preparation-du-lancement-grace-a-la-demarche-patiente-pour-orienter-le-portefeuille\/","title":{"rendered":"De la perte de l\u2019exclusivit\u00e9 \u00e0 la pr\u00e9paration du lancement : l\u2019utilisation de la trajectoire du patient pour orienter un portefeuille"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; collapsed=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; collapsed=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.23.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/branding-science.com\/wp-content\/uploads\/2026\/10\/BSC_4656_Patient-journet-case-study-article-banner-v1.png&#8221; title_text=&#8221;BSC_4656_Patient-journet-case-study-article-banner-v1&#8243; align=&#8221;center&#8221; admin_label=&#8221;Image&#8221; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; background_enable_color=&#8221;off&#8221; width=&#8221;75%&#8221; hover_enabled=&#8221;0&#8243; border_radii=&#8221;on|20px|20px|20px|20px&#8221; box_shadow_style=&#8221;preset1&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;][\/et_pb_image][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div>\n<p>When a brand approaches loss of exclusivity, the challenge is rarely just defending revenue. The bigger question is how to ensure the next asset is positioned to succeed in a market that may look very different from the one your current product entered.<\/p>\n<p>Pharmaceutical companies invest heavily in developing and launching new therapies. Along the way, many seek patient journey insights to better understand the needs of their customers. In the early stages of a brand&#8217;s lifecycle, these studies often help teams identify unmet needs, refine positioning, and build confidence that they are solving a meaningful problem.<\/p>\n<p>But patient needs, treatment paradigms, and competitive landscapes do not stand still. As brands mature, standards of care evolve, new mechanisms emerge, and expectations shift. The patient journey that informed a launch strategy years earlier may no longer provide the answers needed for the next strategic decision.<\/p>\n<\/div>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|300|||||||&#8221; custom_margin=&#8221;||21px|||&#8221; custom_padding=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Preparing a pipeline asset for effective launch<\/h2>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>This was precisely the situation facing one of our clients in immuno-dermatology. Their product was approaching loss of exclusivity, while a pipeline asset represented an opportunity for future growth. However, the disease and treatment landscape had evolved significantly since their original entry into the therapy area. Competition was intensifying, both from impending generics and biosimilars and from emerging pipeline assets seeking to address remaining white space.<\/p>\n<p>The key question was not simply, &#8220;What does today&#8217;s patient journey look like?&#8221; It also needed to consider where meaningful unmet needs still exist, how treatment decisions are being made today, and where a future asset could deliver differentiated value.<\/p>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|300|||||||&#8221; custom_margin=&#8221;||21px|||&#8221; custom_padding=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Creative customisation of a typical patient journey study<\/h2>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>To answer that question, we designed a tailored patient journey programme specifically to inform pre-launch decision-making but at the same time defending the existing asset.<\/p>\n<p>Patients completed a series of video, audio and written pre-work exercises ahead of in-depth interviews. This enabled us to move beyond a surface-level understanding of the treatment pathway and explore the experiences, trade-offs and frustrations that shaped real-world treatment experience. The pre-work also provided rich patient-generated content that was used to create an immersive film by our in-house video production <span data-olk-copy-source=\"MessageBody\">Living Brand Productions<\/span>, which was presented at strategic activation workshops and helped stakeholders connect more deeply with the lived reality of patients.<\/p>\n<p>To ensure individual experiences reflected broader treatment dynamics, we also incorporated HCP perspectives. These conversations validated key themes emerging from patient interviews, enhanced our understanding of treatment decision-making, and explored perceptions of future pipeline assets, including competitive entrants.<\/p>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|300|||||||&#8221; custom_margin=&#8221;||21px|||&#8221; custom_padding=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Generating decision-ready insights<\/h2>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>The research revealed important gaps in the current treatment experience, including areas where existing therapies, including our client&#8217;s own brand, were falling short of patient needs. These insights directly informed clinical endpoint prioritisation, evidence-generation planning and future brand strategy for the client\u2019s pipeline asset.<\/p>\n<p>Most importantly, the work provided a decision-focused view of the patient journey. Rather than creating a comprehensive map for its own sake, the study generated the specific insights needed to guide launch planning in a rapidly evolving market.<\/p>\n<p>As the industry increasingly embraces patient-centricity, it can be tempting to view patient journeys as a standard deliverable. Our experience suggests something different. The most valuable patient journey studies begin not with the methodology, but with the decision they need to inform. In this case, a refreshed understanding of the patient experience helped transform an impending loss of exclusivity from a commercial threat into an opportunity to shape their portfolio.<\/p>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|300|||||||&#8221; custom_margin=&#8221;||21px|||&#8221; custom_padding=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h5>This article was written by: Rosie Dale, Associate Director, US<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>When a brand approaches loss of exclusivity, the challenge is rarely just defending revenue. The bigger question is how to ensure the next asset is positioned to succeed in a market that may look very different from the one your current product entered. Pharmaceutical companies invest heavily in developing and launching new therapies. Along the [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":987512845,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"<p>Here at Branding Science we have been fortunate to assist numerous companies in conducting advisory boards, fostering many insightful discussions with a range of healthcare professionals.<\/p><p>However, these conversations aren\u2019t always a breeze! That\u2019s why we\u2019ve distilled some of our key strategies to ease tension and promote fruitful discussions during ad boards.<\/p><p>In our latest article, we\u2019ve shared our top seven tips to bear in mind if you want to conduct a successful ad board.<\/p><p>To read our thoughts in full, <a href=\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\"https:\/\/branding-science.com\/\/wp-content\/uploads\/2023\/11\/HCP-meeting-PDF_V1.1.pdf\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\" target=\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\"_blank\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\" rel=\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\"noopener\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\">click here<\/a>.<\/p>","_et_gb_content_width":"","footnotes":""},"categories":[18],"tags":[],"class_list":["post-987512835","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>From Loss of Exclusivity to Launch Readiness: Using the Patient Journey to Inform a portfolio | Branding Science<\/title>\n<meta name=\"description\" content=\"When a brand approaches loss of exclusivity, the challenge is rarely just defending revenue. The bigger question is how to ensure the next asset is positioned to succeed in a market that may look very different from the one your current product entered.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/branding-science.com\/fr\/de-la-perte-dexclusivite-a-la-preparation-du-lancement-grace-a-la-demarche-patiente-pour-orienter-le-portefeuille\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"From Loss of Exclusivity to Launch Readiness: Using the Patient Journey to Inform a portfolio | Branding Science\" \/>\n<meta property=\"og:description\" content=\"When a brand approaches loss of exclusivity, the challenge is rarely just defending revenue. The bigger question is how to ensure the next asset is positioned to succeed in a market that may look very different from the one your current product entered.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/branding-science.com\/fr\/de-la-perte-dexclusivite-a-la-preparation-du-lancement-grace-a-la-demarche-patiente-pour-orienter-le-portefeuille\/\" \/>\n<meta property=\"og:site_name\" content=\"Branding Science\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-26T14:02:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-26T14:03:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/branding-science.com\/wp-content\/uploads\/2026\/10\/BSC_4656_Patient-journet-case-study-article-thumbnail-v1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Ciaran Reardon\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ciaran Reardon\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/branding-science.com\\\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/branding-science.com\\\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\\\/\"},\"author\":{\"name\":\"Ciaran Reardon\",\"@id\":\"https:\\\/\\\/branding-science.com\\\/#\\\/schema\\\/person\\\/faa4efac05f4067ab575bad15c8d1f7a\"},\"headline\":\"From Loss of Exclusivity to Launch Readiness: Using the Patient Journey to Inform a portfolio\",\"datePublished\":\"2026-10-26T14:02:51+00:00\",\"dateModified\":\"2026-10-26T14:03:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/branding-science.com\\\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\\\/\"},\"wordCount\":879,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/branding-science.com\\\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/branding-science.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/BSC_4656_Patient-journet-case-study-article-thumbnail-v1.png\",\"articleSection\":[\"Articles\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/branding-science.com\\\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/branding-science.com\\\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\\\/\",\"url\":\"https:\\\/\\\/branding-science.com\\\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\\\/\",\"name\":\"From Loss of Exclusivity to Launch Readiness: Using the Patient Journey to Inform a portfolio | Branding Science\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/branding-science.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/branding-science.com\\\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/branding-science.com\\\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/branding-science.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/BSC_4656_Patient-journet-case-study-article-thumbnail-v1.png\",\"datePublished\":\"2026-10-26T14:02:51+00:00\",\"dateModified\":\"2026-10-26T14:03:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/branding-science.com\\\/#\\\/schema\\\/person\\\/faa4efac05f4067ab575bad15c8d1f7a\"},\"description\":\"When a brand approaches loss of exclusivity, the challenge is rarely just defending revenue. The bigger question is how to ensure the next asset is positioned to succeed in a market that may look very different from the one your current product entered.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/branding-science.com\\\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/branding-science.com\\\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/branding-science.com\\\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/branding-science.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/BSC_4656_Patient-journet-case-study-article-thumbnail-v1.png\",\"contentUrl\":\"https:\\\/\\\/branding-science.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/BSC_4656_Patient-journet-case-study-article-thumbnail-v1.png\",\"width\":800,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/branding-science.com\\\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/branding-science.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"From Loss of Exclusivity to Launch Readiness: Using the Patient Journey to Inform a portfolio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/branding-science.com\\\/#website\",\"url\":\"https:\\\/\\\/branding-science.com\\\/\",\"name\":\"Branding Science\",\"description\":\"Your SUPER-powered WP Engine Site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/branding-science.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/branding-science.com\\\/#\\\/schema\\\/person\\\/faa4efac05f4067ab575bad15c8d1f7a\",\"name\":\"Ciaran Reardon\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67b4b3f69919303c09d853890b4e5d05eafd4cf85688eb7167e57b66c4e71e64?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67b4b3f69919303c09d853890b4e5d05eafd4cf85688eb7167e57b66c4e71e64?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67b4b3f69919303c09d853890b4e5d05eafd4cf85688eb7167e57b66c4e71e64?s=96&d=mm&r=g\",\"caption\":\"Ciaran Reardon\"},\"url\":\"https:\\\/\\\/branding-science.com\\\/fr\\\/author\\\/ciaran\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"De la perte d\u2019exclusivit\u00e9 \u00e0 la pr\u00e9paration du lancement : utiliser le parcours du patient pour orienter un portefeuille | Branding Science","description":"Lorsque les marques doivent faire face \u00e0 une perte d\u2019exclusivit\u00e9, le d\u00e9fi n\u2019est pas seulement de d\u00e9fendre les revenus. La question majeure est de savoir comment assurer que le prochain produit soit bien positionn\u00e9 pour r\u00e9ussir sur un march\u00e9 qui peut \u00eatre tr\u00e8s diff\u00e9rent de celui dans lequel votre produit actuel est entr\u00e9.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/branding-science.com\/fr\/de-la-perte-dexclusivite-a-la-preparation-du-lancement-grace-a-la-demarche-patiente-pour-orienter-le-portefeuille\/","og_locale":"fr_FR","og_type":"article","og_title":"From Loss of Exclusivity to Launch Readiness: Using the Patient Journey to Inform a portfolio | Branding Science","og_description":"When a brand approaches loss of exclusivity, the challenge is rarely just defending revenue. The bigger question is how to ensure the next asset is positioned to succeed in a market that may look very different from the one your current product entered.","og_url":"https:\/\/branding-science.com\/fr\/de-la-perte-dexclusivite-a-la-preparation-du-lancement-grace-a-la-demarche-patiente-pour-orienter-le-portefeuille\/","og_site_name":"Branding Science","article_published_time":"2026-10-26T14:02:51+00:00","article_modified_time":"2026-10-26T14:03:15+00:00","og_image":[{"width":800,"height":500,"url":"https:\/\/branding-science.com\/wp-content\/uploads\/2026\/10\/BSC_4656_Patient-journet-case-study-article-thumbnail-v1.png","type":"image\/png"}],"author":"Ciaran Reardon","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ciaran Reardon","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/branding-science.com\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\/#article","isPartOf":{"@id":"https:\/\/branding-science.com\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\/"},"author":{"name":"Ciaran Reardon","@id":"https:\/\/branding-science.com\/#\/schema\/person\/faa4efac05f4067ab575bad15c8d1f7a"},"headline":"From Loss of Exclusivity to Launch Readiness: Using the Patient Journey to Inform a portfolio","datePublished":"2026-10-26T14:02:51+00:00","dateModified":"2026-10-26T14:03:15+00:00","mainEntityOfPage":{"@id":"https:\/\/branding-science.com\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\/"},"wordCount":879,"commentCount":0,"image":{"@id":"https:\/\/branding-science.com\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\/#primaryimage"},"thumbnailUrl":"https:\/\/branding-science.com\/wp-content\/uploads\/2026\/10\/BSC_4656_Patient-journet-case-study-article-thumbnail-v1.png","articleSection":["Articles"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/branding-science.com\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/branding-science.com\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\/","url":"https:\/\/branding-science.com\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\/","name":"De la perte d\u2019exclusivit\u00e9 \u00e0 la pr\u00e9paration du lancement : utiliser le parcours du patient pour orienter un portefeuille | Branding Science","isPartOf":{"@id":"https:\/\/branding-science.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/branding-science.com\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\/#primaryimage"},"image":{"@id":"https:\/\/branding-science.com\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\/#primaryimage"},"thumbnailUrl":"https:\/\/branding-science.com\/wp-content\/uploads\/2026\/10\/BSC_4656_Patient-journet-case-study-article-thumbnail-v1.png","datePublished":"2026-10-26T14:02:51+00:00","dateModified":"2026-10-26T14:03:15+00:00","author":{"@id":"https:\/\/branding-science.com\/#\/schema\/person\/faa4efac05f4067ab575bad15c8d1f7a"},"description":"Lorsque les marques doivent faire face \u00e0 une perte d\u2019exclusivit\u00e9, le d\u00e9fi n\u2019est pas seulement de d\u00e9fendre les revenus. La question majeure est de savoir comment assurer que le prochain produit soit bien positionn\u00e9 pour r\u00e9ussir sur un march\u00e9 qui peut \u00eatre tr\u00e8s diff\u00e9rent de celui dans lequel votre produit actuel est entr\u00e9.","breadcrumb":{"@id":"https:\/\/branding-science.com\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/branding-science.com\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/branding-science.com\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\/#primaryimage","url":"https:\/\/branding-science.com\/wp-content\/uploads\/2026\/10\/BSC_4656_Patient-journet-case-study-article-thumbnail-v1.png","contentUrl":"https:\/\/branding-science.com\/wp-content\/uploads\/2026\/10\/BSC_4656_Patient-journet-case-study-article-thumbnail-v1.png","width":800,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/branding-science.com\/from-loss-of-exclusivity-to-launch-readiness-using-the-patient-journey-to-inform-a-portfolio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/branding-science.com\/"},{"@type":"ListItem","position":2,"name":"From Loss of Exclusivity to Launch Readiness: Using the Patient Journey to Inform a portfolio"}]},{"@type":"WebSite","@id":"https:\/\/branding-science.com\/#website","url":"https:\/\/branding-science.com\/","name":"Science de l'image de marque","description":"Votre site WP Engine SUPER-puissant","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/branding-science.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/branding-science.com\/#\/schema\/person\/faa4efac05f4067ab575bad15c8d1f7a","name":"Ciaran Reardon","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/67b4b3f69919303c09d853890b4e5d05eafd4cf85688eb7167e57b66c4e71e64?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/67b4b3f69919303c09d853890b4e5d05eafd4cf85688eb7167e57b66c4e71e64?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67b4b3f69919303c09d853890b4e5d05eafd4cf85688eb7167e57b66c4e71e64?s=96&d=mm&r=g","caption":"Ciaran Reardon"},"url":"https:\/\/branding-science.com\/fr\/author\/ciaran\/"}]}},"_links":{"self":[{"href":"https:\/\/branding-science.com\/fr\/wp-json\/wp\/v2\/posts\/987512835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/branding-science.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/branding-science.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/branding-science.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/branding-science.com\/fr\/wp-json\/wp\/v2\/comments?post=987512835"}],"version-history":[{"count":7,"href":"https:\/\/branding-science.com\/fr\/wp-json\/wp\/v2\/posts\/987512835\/revisions"}],"predecessor-version":[{"id":987512847,"href":"https:\/\/branding-science.com\/fr\/wp-json\/wp\/v2\/posts\/987512835\/revisions\/987512847"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/branding-science.com\/fr\/wp-json\/wp\/v2\/media\/987512845"}],"wp:attachment":[{"href":"https:\/\/branding-science.com\/fr\/wp-json\/wp\/v2\/media?parent=987512835"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/branding-science.com\/fr\/wp-json\/wp\/v2\/categories?post=987512835"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/branding-science.com\/fr\/wp-json\/wp\/v2\/tags?post=987512835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}